Akamai Technologies (AKAM) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.41%. A quarter ago, it was expected that this cloud services provider would post earnings of $1.55 per share when it actually produced earnings of $1.73, delivering a surprise of +11.61%.Over the last four ...

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to a loss of $1.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.80%. A quarter ago, it was expected that this company would post a loss of $1.03 per share when it actually produced a loss of $0.99, delivering a surprise of +3.88%.Over the last four quarters, the compan ...

最新季度业绩表现 - 季度每股收益为0.86美元，低于Zacks普遍预期的1.09美元，同比下降4.4%，业绩意外为-21.10% [1] - 季度营收为18.3亿美元，超出Zacks普遍预期3.88%，同比增长8.3% [2] - 在过去四个季度中，公司仅一次超出每股收益预期，但有两次超出营收预期 [2] 近期股价表现与未来展望 - 公司股价年初至今上涨约45.3%，表现优于标普500指数15.6%的涨幅 [3] - 业绩公布前，盈利预期修正趋势向好，Zacks评级为第1级（强力买入），预计近期将跑赢市场 [6] - 对下一季度的普遍预期为每股收益1.43美元，营收18.3亿美元；当前财年普遍预期为每股收益4.53美元，营收70.2亿美元 [7] 行业比较与同业公司 - 所属的博彩行业在Zacks 250多个行业中排名前33% [8] - 同业公司Super League Enterprise预计季度每股亏损2.83美元，同比改善86.9%，预计营收为379万美元，同比下降14.5% [9][10]

QXO, Inc. (QXO) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +16.67%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings of $0.11, delivering a surprise of +175%. Over the last four quarters, the company has ...

Investors might want to bet on Neurocrine Biosciences (NBIX) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.Analysts' growing optimism on the earnings prospects of this biopharmaceutical company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between tren ...

核心观点 - 投资者可能希望投资Flushing Financial (FFIC)，因该公司盈利预期近期持续显著改善，且股价已展现强劲的短期动能，这一趋势可能随盈利前景向好而延续 [1] 盈利预期修正趋势 - 对这家Flushing Bank控股公司盈利预期的向上修正趋势反映了分析师对其盈利前景日益乐观，这应会体现在其股价中 [2] - 实证研究显示盈利预期修正趋势与短期股价变动之间存在强相关性 [2] - 覆盖该公司的分析师在调升预期方面表现出高度一致，推动下一季度和全年的共识盈利预期大幅上调 [3] 当前季度盈利预期 - 当前季度，公司预计每股收益为0.35美元，较去年同期报告的数值增长150.0% [6] - 过去30天内，有两项对Flushing Financial的预期被上调，无负面修正，导致Zacks共识预期提升了15% [6] 本年度盈利预期 - 全年来看，公司预计每股收益为1.24美元，同比增长69.9% [7] - 本年度的修正趋势同样乐观，过去一个月有两项预期上调而无负面修正，共识预期在此期间提升了5.68% [7][8] Zacks评级与表现 - 有利的预期修正帮助Flushing Financial获得了Zacks Rank 1 (强力买入) 的评级 [9] - Zacks Rank 1 的股票自2008年以来实现了平均每年+25%的回报率 [3] - 研究显示，Zacks Rank 1 和 2 的股票表现显著超越标普500指数 [9] 股价表现与投资建议 - 强劲的预期修正已吸引可观投资，推动该股在过去四周上涨5.8%，但认为股价可能仍有进一步上行空间 [10]

Roku (ROKU) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.Analysts' growing optimism on the earnings prospects of this video streaming company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stoc ...

Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this drug developer is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earning ...

Great Lakes Dredge & Dock (GLDD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The p ...

评级升级与核心观点 - 加拿大自然资源公司（CNQ）的Zacks评级被上调至第1级（强力买入）[1] - 此次评级上调反映了其盈利预期的上升趋势 这是影响股价的最强大力量之一 [1] - 评级上调意味着市场对其盈利前景持乐观态度 可能转化为买入压力并推动股价上涨 [3] Zacks评级系统方法论 - Zacks评级完全基于公司盈利预期的变化 通过追踪卖方分析师对当前及下一财年的每股收益（EPS）预期共识来衡量 [1] - 该系统将股票分为五组 Zacks Rank 1（强力买入）股票自1988年以来实现了平均25%的年化回报率 [7] - 该评级系统在任何时间点对其覆盖的4000多只股票均保持“买入”和“卖出”评级比例相等 仅有前5%的股票获得“强力买入”评级 [9] 盈利预期修正的影响 - 公司未来盈利潜力的变化 具体体现为盈利预期的修正 已被证明与股票短期价格走势高度相关 [4] - 机构投资者利用盈利预期计算公司股票的公平价值 其模型中的盈利预期上调或下调会直接导致股票公平价值的升高或降低 进而引发大宗买卖行为并推动股价变动 [4] - 实证研究表明盈利预期修正趋势与短期股价波动之间存在强相关性 跟踪这些修正对于投资决策可能带来回报 [6] 加拿大自然资源公司具体数据 - 这家石油和天然气公司预计在2025财年每股收益为2.43美元 与上年相比没有变化 [8] - 在过去三个月中 该公司的Zacks共识预期已上调6.3% [8] - 评级上调至Zacks Rank 1使其在盈利预期修正方面位列Zacks覆盖股票的前5% 暗示其股价可能在近期走高 [10]